Sativex (THC+CBD) and oral THC alone produced similar effects at therapeutic doses, with no evidence CBD reduced THC side effects | Research

The takeaway

In 9 cannabis smokers, Sativex and equivalent oral THC doses produced similar, mild increases in heart rate and anxiety, with no evidence that CBD in Sativex attenuated THC's effects at therapeutic doses.

Read this if you are interested in whether the CBD component of Sativex actually modifies the THC experience.

No CBD-induced modulation of THC effects at therapeutic doses

What the researchers found

Nine cannabis smokers received five treatments in randomized, double-blind fashion: placebo, low and high doses of oral synthetic THC, and low and high doses of Sativex (1:1 THC:CBD oromucosal spray).

At therapeutic doses, Sativex and oral THC produced similar, clinically insignificant increases in heart rate, anxiety, and "good drug effects." No serious adverse events occurred with either treatment.

Contrary to the hypothesis that CBD would attenuate THC-induced side effects, no substantial CBD-induced modulation of THC's effects was evident at these dose levels. Oral and oromucosal THC delivery had slower absorption and lower brain delivery rates compared to smoked cannabis, resulting in fewer adverse events.

The authors concluded that Sativex had a safety profile comparable to oral THC at low, therapeutic doses.

Why it matters

The finding that CBD did not noticeably reduce THC effects at therapeutic doses challenged a key marketing claim about Sativex and had implications for how combination products were understood and prescribed.

The numbers in context

9 participants. Sativex low: 5.4 mg THC + 5.0 mg CBD. Sativex high: 16.2 mg THC + 15.0 mg CBD. Oral THC: 5 and 15 mg. Similar effects across equivalent THC-dose conditions. No serious adverse events.

How the study worked

Randomized, double-blind, placebo-controlled, five-session crossover study in 9 cannabis smokers. Treatments: placebo, 5 and 15 mg oral THC, low-dose Sativex (5.4 mg THC + 5.0 mg CBD), high-dose Sativex (16.2 mg THC + 15.0 mg CBD). Pharmacodynamic assessments over 10.5 hours.

What this study cannot tell us

Very small sample (9 participants). Cannabis smokers may have different sensitivity than naive users. Only therapeutic doses tested; CBD modulation might emerge at higher doses. Single-dose sessions only.

How to read the evidence

Randomized, double-blind crossover study with appropriate controls but very small sample size (9 participants).

When this study was published

Published in 2011. The question of CBD-THC interaction continues to be studied.

The bigger picture

This study contributed to the ongoing debate about whether CBD meaningfully modifies THC effects in pharmaceutical products, an important question for clinical cannabinoid development.

Questions still open

Does CBD modulate THC effects at higher doses or with chronic administration? Is the similar safety profile sufficient to justify Sativex over pure oral THC?

Common questions

Does CBD in Sativex reduce THC side effects?

At the therapeutic doses tested in this study, CBD did not noticeably reduce THC's effects on heart rate, anxiety, or subjective drug effects. Sativex and pure oral THC had similar safety profiles.

Is Sativex safer than pure THC?

At these doses, Sativex and oral THC produced similar, mild effects. Both were safer than smoked cannabis due to slower absorption and lower peak brain delivery of THC.

Read the original research

Subjective and physiological effects after controlled Sativex and oral THC administration.

Clinical pharmacology and therapeutics, 89(3), 400-7

View on PubMed ↗Publisher’s paper ↗

Citation

Karschner, E L; Darwin, W D; McMahon, R P; Liu, F; Wright, S; Goodwin, R S; Huestis, M A. (2011). Subjective and physiological effects after controlled Sativex and oral THC administration.. Clinical pharmacology and therapeutics, 89(3), 400-7. https://doi.org/10.1038/clpt.2010.318